Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Courtney L Fisher

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Cerebrovascular Diseases Extra|May 1, 2019
Nonsteroidal Anti-Inflammatory Drugs: A Potential Pharmacological Treatment for Intracranial AneurysmCourtney L Fisher, Stacie L Demel
Journal of Hypertension|August 9, 2022
Mineralocorticoid receptor antagonism improves transient receptor potential vanilloid 4-dependent dilation of cerebral parenchymal arterioles and cognition in a genetic model of hypertensionLaura C Chambers, Janice M Diaz-Otero, Courtney L Fisher, et al.
Journal of Medicinal Chemistry|November 11, 2022
Structure-Activity Studies of 1<i>H</i>-Imidazo[4,5-<i>c</i>]quinolin-4-amine Derivatives as A<sub>3</sub> Adenosine Receptor Positive Allosteric ModulatorsLucas B Fallot, R Rama Suresh, Courtney L Fisher, et al.
ACS Pharmacology & Translational Science|September 14, 2023
First Potent Macrocyclic A<sub>3</sub> Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling PreferencesDilip K Tosh, Courtney L Fisher, Veronica Salmaso, et al.
Molecular Pharmacology|January 5, 2024
Extrahelical Binding Site for a 1<i>H</i>-Imidazo[4,5-c]quinolin-4-amine A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulator on Helix 8 and Distal Portions of Transmembrane Domains 1 and 7Courtney L Fisher, Matteo Pavan, Veronica Salmaso, et al.
Journal of Medicinal Chemistry|April 10, 2020
Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A<sub>3</sub> Adenosine Receptors: Affinity Enhancement by <i>N</i><sup>6</sup>-(2-Phenylethyl) SubstitutionDilip K Tosh, Veronica Salmaso, Harsha Rao, et al.
ACS Pharmacology & Translational Science|August 19, 2022
Characterization of Dual-Acting A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gα<sub>i3</sub> and Gα<sub>oA</sub> Isoprotein ActivationCourtney L Fisher, Lucas B Fallot, Tina C Wan, et al.
Journal of Medicinal Chemistry|July 3, 2024
Lipid Trolling to Optimize A<sub>3</sub> Adenosine Receptor-Positive Allosteric Modulators (PAMs)Balaram Pradhan, Matteo Pavan, Courtney L Fisher, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Cerebrovascular Diseases Extra|May 1, 2019
Nonsteroidal Anti-Inflammatory Drugs: A Potential Pharmacological Treatment for Intracranial AneurysmCourtney L Fisher, Stacie L Demel
Journal of Hypertension|August 9, 2022
Mineralocorticoid receptor antagonism improves transient receptor potential vanilloid 4-dependent dilation of cerebral parenchymal arterioles and cognition in a genetic model of hypertensionLaura C Chambers, Janice M Diaz-Otero, Courtney L Fisher, et al.
Journal of Medicinal Chemistry|November 11, 2022
Structure-Activity Studies of 1<i>H</i>-Imidazo[4,5-<i>c</i>]quinolin-4-amine Derivatives as A<sub>3</sub> Adenosine Receptor Positive Allosteric ModulatorsLucas B Fallot, R Rama Suresh, Courtney L Fisher, et al.
ACS Pharmacology & Translational Science|September 14, 2023
First Potent Macrocyclic A<sub>3</sub> Adenosine Receptor Agonists Reveal G-Protein and β-Arrestin2 Signaling PreferencesDilip K Tosh, Courtney L Fisher, Veronica Salmaso, et al.
Molecular Pharmacology|January 5, 2024
Extrahelical Binding Site for a 1<i>H</i>-Imidazo[4,5-c]quinolin-4-amine A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulator on Helix 8 and Distal Portions of Transmembrane Domains 1 and 7Courtney L Fisher, Matteo Pavan, Veronica Salmaso, et al.
Journal of Medicinal Chemistry|April 10, 2020
Truncated (N)-Methanocarba Nucleosides as Partial Agonists at Mouse and Human A<sub>3</sub> Adenosine Receptors: Affinity Enhancement by <i>N</i><sup>6</sup>-(2-Phenylethyl) SubstitutionDilip K Tosh, Veronica Salmaso, Harsha Rao, et al.
ACS Pharmacology & Translational Science|August 19, 2022
Characterization of Dual-Acting A<sub>3</sub> Adenosine Receptor Positive Allosteric Modulators That Preferentially Enhance Adenosine-Induced Gα<sub>i3</sub> and Gα<sub>oA</sub> Isoprotein ActivationCourtney L Fisher, Lucas B Fallot, Tina C Wan, et al.
Journal of Medicinal Chemistry|July 3, 2024
Lipid Trolling to Optimize A<sub>3</sub> Adenosine Receptor-Positive Allosteric Modulators (PAMs)Balaram Pradhan, Matteo Pavan, Courtney L Fisher, et al.
Pageof 1